Trial Profile
A randomized, single center, double blind, two period, crossover glucose clamp study to test for bioequivalence between two recombinant human soluble insulins- Wockhardts insulin human regular for injection and Novolin R [insulin] in healthy subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Jan 2013
Price :
$35
*
At a glance
- Drugs Insulin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Wockhardt
- 11 Mar 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 02 Feb 2008 New trial record.